Su X - Search Results

1

miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD.

Su X, Gao C, Feng X, Jiang M. Su X, et al. Exp Ther Med. 2020 Apr;19(4):3081-3089. doi: 10.3892/etm.2020.8540. Epub 2020 Feb 21. Exp Ther Med. 2020. Retraction in: Exp Ther Med. 2023 Oct 10;26(6):547. doi: 10.3892/etm.2023.12246 PMID: 32256796 Free PMC article. Retracted.

2

A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance.

Su X, Gao C, Shi F, Feng X, Liu L, Qu D, Wang C. Su X, et al. Drug Deliv. 2017 Nov;24(1):10-19. doi: 10.1080/10717544.2016.1225854. Drug Deliv. 2017. PMID: 28155336 Free PMC article.

3

Immunomodulatory effects of chemotherapy on blood lymphocytes and survival of patients with advanced non-small cell lung cancer.

Aldarouish M, Su X, Qiao J, Gao C, Chen Y, Dai A, Zhang T, Shu Y, Wang C. Aldarouish M, et al. Among authors: su x. Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419839592. doi: 10.1177/2058738419839592. Int J Immunopathol Pharmacol. 2019. PMID: 30968711 Free PMC article.

4

ROR promotes the proliferation and migration of esophageal cancer through regulating miR-145/LMNB2 signal axis.

Su X, Feng X, Gao C, Wang G, Liu L. Su X, et al. Am J Transl Res. 2020 Nov 15;12(11):7223-7235. eCollection 2020. Am J Transl Res. 2020. PMID: 33312362 Free PMC article.

5

Ultrasound-Stimulated Microbubbles Inhibit Aggressive Phenotypes and Promotes Radiosensitivity of esophageal squamous cell carcinoma.

Shi J, Fu C, Su X, Feng S, Wang S. Shi J, et al. Among authors: su x. Bioengineered. 2021 Dec;12(1):3000-3013. doi: 10.1080/21655979.2021.1931641. Bioengineered. 2021. PMID: 34180353 Free PMC article.

6

Ultrasound-stimulated microbubbles contributes to radiotherapy in esophageal carcinoma.

Fu C, Shi J, Su X, Feng S, Wang S. Fu C, et al. Among authors: su x. Biochem Cell Biol. 2021 Dec;99(6):707-716. doi: 10.1139/bcb-2021-0061. Epub 2021 Nov 1. Biochem Cell Biol. 2021. PMID: 34723651

7

Development and validation of a prognostic model for esophageal carcinoma based on immune microenvironment using system bioinformatics.

Fu C, Feng S, Wang S, Su X. Fu C, et al. Among authors: su x. Cancer Med. 2023 Jan;12(2):2089-2103. doi: 10.1002/cam4.4985. Epub 2022 Jun 30. Cancer Med. 2023. PMID: 35771026 Free PMC article.

8

T-cell exhaustion prediction algorithm in tumor microenvironment for evaluating prognostic stratification and immunotherapy effect of esophageal cancer.

Su X, Fu C, Liu F, Bian R, Jing P. Su X, et al. Environ Toxicol. 2024 Feb;39(2):592-611. doi: 10.1002/tox.23887. Epub 2023 Jul 26. Environ Toxicol. 2024. PMID: 37493251

9

The role of JMJD2A in immune evasion and malignant behavior of esophageal squamous cell carcinoma.

Su X, Ding X, Ding C, Wang G, Fu C, Liu F, Shi J, He W. Su X, et al. Int Immunopharmacol. 2024 Aug 20;137:112401. doi: 10.1016/j.intimp.2024.112401. Epub 2024 Jun 14. Int Immunopharmacol. 2024. PMID: 38878485

10

Knockdown of WISP1/DKK1 restrains phenotypic plasticity in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition and stemness.

Fu C, Lu Z, Shi J, Liu F, Su X. Fu C, et al. Among authors: su x. Clin Transl Oncol. 2024 Aug 2. doi: 10.1007/s12094-024-03639-6. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39093516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,638 results

Search Page

Filters